Picture of Abcam logo

ABCM Abcam Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+4.31%
3m+12.54%
6m+5.66%
1yr-17.18%
Volume Change (%)
10d/3m+95.55%
Price vs... (%)
52w High-34.13%
50d MA+1.52%
200d MA+1.54%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)35.89
PEG Ratio (f)1.82
EPS Growth (f)24.56%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value3.99
Price to Tang. Book28.56
Price to Free Cashflow166.95
Price to Sales8.29
EV to EBITDA56.65

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital0.64%
Return on Equity1%
Operating Margin1.57%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue£m217.1233.2259.9260462.9386.85439.8321.94%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+7.37+84.8-15.35-31.45+5.48+17.68+24.97n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Abcam EPS forecast chart

Profile Summary

Abcam plc is a United Kingdom-based life science company. The Company is engaged in the identification, development and distribution of biological reagents. The Company’s products are used by various researchers worldwide to study biological pathways critical for scientific research, diagnostics and drug discovery. Its products can be grouped into two categories: research use only (RUO) proteomic tools and antibodies for clinical application. RUO products include protein binding reagents, such as antibodies and immunoassays, and related reagents. Its RUO products are used to detect, quantify, visualize and modify proteins in scientific research experiments, serving as vital tools to enable its customers to develop insights about targets and biological pathways of interest. Antibodies are a core component of many in vitro diagnostic assays and can also be used as therapeutic agents to treat various diseases, including cancer.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
February 12th, 1998
Public Since
November 3rd, 2005
No. of Employees
1,750
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
229,271,907
Blurred out image of a map
Address
Discovery Drive, CAMBRIDGE, CB20AX
Web
http://www.abcam.com/
Phone
+44 1223696000
Auditors
PricewaterhouseCoopers LLP

ABCM Share Price Performance

Latest News for ABCM

Similar to ABCM

Picture of Amgen logo

Amgen

us flag iconNASDAQ Global Select Market

Picture of Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals

us flag iconNASDAQ Global Select Market

Picture of Amryt Pharma logo

Amryt Pharma

us flag iconNASDAQ Global Select Market

Picture of Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

us flag iconNASDAQ Global Select Market

Picture of Anika Therapeutics logo

Anika Therapeutics

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email